Persantine-aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirin

Journal of the American College of Cardiology

Volumn 7, Issue 2, 1986, Pages 251-269

  Klimt, Christian R ^a   Knatterud, Genell L ^a   Stamler, Jeremiah ^a   Meier, Paul ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; PLACEBO;

BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIOLOGY; FOLLOW UP; HEART; HEART INFARCTION; HUMAN; MORTALITY; PERIPHERAL VASCULAR SYSTEM; PREVENTION; PRIORITY JOURNAL; REINFARCTION; THERAPY;

EID: 0022642151     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(86)80489-2     Document Type: Article

References (32)

1. Platelet inhibition in the management of thrombosis
2. Long-term therapy in the prevention of thrombosis
3. Effect of a pyrimido-pyrimidine derivative on thrombus formation in the rabbit
4. Studies of platelet destruction due to prosthetic arteriovenous cannulas
5. Pharmacologic control of thromboembolic complications of cardiac-valve replacement
6. The effect of platelet inhibition on platelet phenomena during cardiopulmonary bypass in pigs
7. In vivo evaluation of antithrombotic therapy in man
8. Inhibition of platelet-induced thrombus formation
9. The effect of dipyridamole on platelet function: correlation with blood levels in man
10. Dipyridamole and platelet function (letter)
11. Mechanism of action of dipyridamole
12. Ergebnisse einer Studie zur Prophylaxe der Progredienz einer arteriellen Verschlusskrankheit mit Thrombozytenfunktionshemmern
13. Antiplatelet therapy for thrombosic thrombocytopenic purpura
14. Effect of dipyridamole and aspirin in thrombosic micro-angiopathy
15. Effect of acetylsalicylic acid and dipyridamole on platelet survival and aggregation in patients with atherosclerosis obliterans
16. Effects of platelet-modifying drugs on arterial thromboembolism in baboons: aspirin potentiates the antithrombolytic action of dipyridamole and sulfinpyrazone by mechanism independent of cyclooxygenase inhibition
17. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency
18. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations
19. Persantine and aspirin in coronary heart disease
20. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction
21. PersantineAspirin Reinfarction Study. Design, methods and baseline results
22. Monitoring long-term clinical trials for beneficial and adverse treatment effects
23. Nonparametric estimation from incomplete observations
24. Regression models and life tables
25. Choice of covariates in the adjustment of treatment effects
26. BMDP2L
27. Clofibrate and niacin in coronary heart disease
28. Mortality in Coronary Drug Project patients during a nineyear post-treatment period (abstr)
29. Factors presaging early recurrent myocardial infarction (“extension”)
30. A randomized trial of propranolol in patients with acute myocardial infarction